Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs
![Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs](https://www.hartwigmedicalfoundation.nl/wp-content/uploads/2021/12/personalised-medicine-adobestock_195638130-alleen-bij-art-AvL-gebruiken.jpeg)
A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be relevant for treating metastatic cancer. This is because actionable DNA errors remain remarkably stable over time, despite treatment with drugs. This discovery was made by Dutch researchers in a study led by the Netherlands Cancer Institute. The researchers used data from the Hartwig Medical Database for their research. They published their findings on August 9 online in the scientific journal Nature Medicine.
More information
- Publication in Nature: Joris van de Haar et al, ‘Limited evolution of the actionable metastatic cancer genome under therapeutic pressure’
- Read the complete article on the Antoni van Leeuwenhoek website
- Paper in The Journal of Molecular Diagnostics: Clinical validation of Whole Genome Sequencing for cancer diagnostics
- Video voor treating physicians and pathologists about one-time analysis of the entire tumor DNA
- More information about WGS and the extensive DNA test for Cancer Diagnostics: OncoAct.nl
All news
Also read
![New cancer treatment options created by full DNA-analysis](https://www.hartwigmedicalfoundation.nl/wp-content/uploads/2021/12/drup-logo-zonder-tekst.png)
New cancer treatment options created by full DNA-analysis
Nature publication reports study by Netherlands Center for Personalized Cancer Treatment showing benefits for targeted treatments outside registered indications 2 …
![In the media: Rarity – Personalised cancer treatment – fact not fiction](https://www.hartwigmedicalfoundation.nl/wp-content/uploads/2022/04/HansvanSnellenberg3996_NIEUW-2-1024x913.jpg)
In the media: Rarity – Personalised cancer treatment – fact not fiction
Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …
![Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice](https://www.hartwigmedicalfoundation.nl/wp-content/uploads/2024/07/Alena-Gros-2-1024x683.jpg)
Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice
By Laura Nederveen In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …
![](https://www.hartwigmedicalfoundation.nl/wp-content/uploads/2023/04/Schermafbeelding-2023-04-14-om-14.27.58.png)
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.